Oppenheimer Has Lowered Expectations for Varex Imaging (NASDAQ:VREX) Stock Price

Varex Imaging (NASDAQ:VREX) had its price target lowered by equities research analysts at Oppenheimer from $23.00 to $18.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s target price indicates a potential upside of 79.73% from the stock’s previous close.

A number of other equities research analysts have also recently issued reports on VREX. B. Riley reaffirmed a “buy” rating and issued a $16.00 target price on shares of Varex Imaging in a report on Wednesday. Wall Street Zen lowered Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Varex Imaging in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Varex Imaging presently has an average rating of “Hold” and a consensus target price of $17.00.

Varex Imaging Stock Down 15.6%

Shares of NASDAQ:VREX traded down $1.85 during trading on Wednesday, hitting $10.02. 450,692 shares of the company were exchanged, compared to its average volume of 424,450. Varex Imaging has a fifty-two week low of $6.76 and a fifty-two week high of $16.93. The stock has a market cap of $415.62 million, a price-to-earnings ratio of -3.14 and a beta of 0.98. The company has a current ratio of 3.51, a quick ratio of 1.82 and a debt-to-equity ratio of 0.78. The firm has a fifty day moving average price of $11.83 and a two-hundred day moving average price of $9.84.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.19. Varex Imaging had a negative net margin of 16.13% and a positive return on equity of 5.54%. The business had revenue of $228.90 million during the quarter, compared to analysts’ expectations of $219.26 million. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, research analysts anticipate that Varex Imaging will post 0.53 earnings per share for the current fiscal year.

Institutional Trading of Varex Imaging

Large investors have recently made changes to their positions in the company. State of Alaska Department of Revenue acquired a new position in Varex Imaging during the third quarter valued at approximately $27,000. Quarry LP acquired a new position in Varex Imaging during the 1st quarter worth approximately $63,000. BNP Paribas Financial Markets boosted its position in Varex Imaging by 18.5% in the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after buying an additional 2,036 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Varex Imaging by 25.5% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 13,104 shares of the company’s stock worth $115,000 after buying an additional 2,659 shares during the last quarter. Finally, Aquatic Capital Management LLC acquired a new position in shares of Varex Imaging during the third quarter worth $117,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.